BR0307039A - Compostos, em particular de derivados uréias ou ésteres do ácido haloacetamidobenzóico e sua utilização para o tratamento de doenças parasitárias - Google Patents

Compostos, em particular de derivados uréias ou ésteres do ácido haloacetamidobenzóico e sua utilização para o tratamento de doenças parasitárias

Info

Publication number
BR0307039A
BR0307039A BR0307039-5A BR0307039A BR0307039A BR 0307039 A BR0307039 A BR 0307039A BR 0307039 A BR0307039 A BR 0307039A BR 0307039 A BR0307039 A BR 0307039A
Authority
BR
Brazil
Prior art keywords
treatment
esters
parasitic diseases
compounds
urea derivatives
Prior art date
Application number
BR0307039-5A
Other languages
English (en)
Inventor
Patrice Lepape
Esther Suzy Arlette Fellous
Julius George Bekesi
Original Assignee
Jorge Elias Kalil Jr
Patrice Lepape
Esther Suzy Arlette Fellous
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jorge Elias Kalil Jr, Patrice Lepape, Esther Suzy Arlette Fellous filed Critical Jorge Elias Kalil Jr
Publication of BR0307039A publication Critical patent/BR0307039A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A61K31/24—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group having an amino or nitro group
    • A61K31/245—Amino benzoic acid types, e.g. procaine, novocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/17—Amides, e.g. hydroxamic acids having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

"COMPOSTOS, EM PARTICULAR DE DERIVADOS URéIAS OU éSTERES DO áCIDO HALOACETAMIDOBENZóICO E SUA UTILIZAçãO PARA O TRATAMENTO DE DOENçAS PARASITáRIAS". A invenção refere-se a uma utilização de um composto de fórmula geral (I) para a produção de um medicamento destinado ao tratamento das doenças parasitárias, em particular da leishmaniose.
BR0307039-5A 2002-01-31 2003-01-31 Compostos, em particular de derivados uréias ou ésteres do ácido haloacetamidobenzóico e sua utilização para o tratamento de doenças parasitárias BR0307039A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0201151A FR2835253B1 (fr) 2002-01-31 2002-01-31 Composes, en particulier de derives urees ou esters de l'acide haloacetamidobenzoique et leur utilisation pour le traitement de maladies parasitaires
PCT/FR2003/000289 WO2003063858A2 (fr) 2002-01-31 2003-01-31 Derives de l'acide haloacetamidobenzoique et leur utilisation pour le traitement de maladies parasitaires

Publications (1)

Publication Number Publication Date
BR0307039A true BR0307039A (pt) 2004-10-26

Family

ID=27619780

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0307039-5A BR0307039A (pt) 2002-01-31 2003-01-31 Compostos, em particular de derivados uréias ou ésteres do ácido haloacetamidobenzóico e sua utilização para o tratamento de doenças parasitárias

Country Status (10)

Country Link
US (1) US20050165068A1 (pt)
EP (1) EP1469845B1 (pt)
CN (1) CN100490799C (pt)
AT (1) ATE369849T1 (pt)
AU (1) AU2003216965A1 (pt)
BR (1) BR0307039A (pt)
DE (1) DE60315597T2 (pt)
ES (1) ES2295567T3 (pt)
FR (1) FR2835253B1 (pt)
WO (1) WO2003063858A2 (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10227320B2 (en) 2015-05-06 2019-03-12 University Of Maryland, College Park Compounds for treating parasitic infections
WO2017127627A1 (en) 2016-01-21 2017-07-27 The University Of North Carolina At Chapel Hill Compounds for treatment of trypanosomes and neurological pathogens and uses thereof
CN110996939A (zh) * 2017-08-03 2020-04-10 诺克斯生物公司 用于治疗皮肤利什曼病的方法的组合物
EP3449906A1 (en) * 2017-09-04 2019-03-06 AC Biotech Topical composition for use in treating cutaneous leishmaniasis

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE106502C (pt) *
JPS5848545B2 (ja) * 1974-04-18 1983-10-28 キツセイヤクヒンコウギヨウ カブシキガイシヤ シンキホウコウゾクカルボンサンアミドユウドウタイ ノ セイゾウホウホウ
US5886025A (en) * 1997-03-06 1999-03-23 Baylor University Anti-mitotic agents which inhibit tubulin polymerization
US6943196B1 (en) * 1998-03-20 2005-09-13 Daiichi Suntory Pharma Co., Ltd. NF-κB inhibitor comprising phenylmethyl benzoquinone as the active ingredient
US6294695B1 (en) * 1998-03-26 2001-09-25 Mount Sinai School Of Medicine Of The City University Of New York Aminobenzoic acid derivatives having anti-tumorigenic activity methods of making and using the same
AU7511800A (en) * 1999-08-30 2001-03-26 K.U. Leuven Research And Development Novel target for antiparasitic agents and inhibitors thereof
US7259278B2 (en) * 2000-11-29 2007-08-21 Cytoskeleton Inc. Anti-S-phase tubulin ligands

Also Published As

Publication number Publication date
DE60315597T2 (de) 2008-05-08
AU2003216965A1 (en) 2003-09-02
ATE369849T1 (de) 2007-09-15
CN100490799C (zh) 2009-05-27
WO2003063858A2 (fr) 2003-08-07
FR2835253B1 (fr) 2008-02-01
EP1469845A2 (fr) 2004-10-27
DE60315597D1 (de) 2007-09-27
ES2295567T3 (es) 2008-04-16
FR2835253A1 (fr) 2003-08-01
WO2003063858A3 (fr) 2004-03-25
US20050165068A1 (en) 2005-07-28
EP1469845B1 (fr) 2007-08-15
CN1625396A (zh) 2005-06-08

Similar Documents

Publication Publication Date Title
BRPI0409109A (pt) novos compostos
BR0315720A (pt) Composto, método para a profilaxia ou tratamento de uma condição clìnica em um mamìmefero, formulação farmacêutica, combinação, uso de um composto, processo para a preparação de um composto, e, intermediário
ATE339187T1 (de) Verwendung von zusammensetzungen mit antiseptika und/oder die wundheilung fördernden wirkstoffen für den tieferen atemwegstrakt
BRPI0413490A (pt) novos compostos
BRPI0411255A (pt) composto, composição farmacêutica, uso de um composto, métodos de tratar um distúrbio de um paciente, e, processo para a preparação de um composto
BR9909565A (pt) Derivados bicìclicos do ácido hidroxâmico
ATE365720T1 (de) Agonisten von beta-adrenorezeptoren
PT1326613E (pt) Utilizacao de derivados de imidazo[1,2-a]piridin-,imidazo[1,2-a]pirimidin- e imidazo[1,2-a]pirazin-3-il-amina substituidos para a fabricacao de medicamentos para inibicao de nos
BRPI0212455B8 (pt) composto derivado de fenetanolamina para o tratamento de doenças respiratórias, formulação farmacêutica, combinação, e, uso do mesmo
BR0215240A (pt) Derivados de calcona e seu uso no tratamento de doenças
BRPI0512253A (pt) composto, formulação farmacêutica, uso de um composto, método de tratamento de uma doença, produto combinado, e, processo para a preparação de um composto
BR0114092A (pt) Guanididas de ácido cinámico substituìdas, processos para a sua preparação, sua aplicação como medicamento bem como o medicamento contendo as mesmas
ECSP034883A (es) Amidas de acidos antranilicos con cadena lateral de heteroarilsulfonilo, procedimiento para su preparacion, su empleo como medicamento o agente de diagnostico, asi como preparados farmaceuticos que las contienen
ATE476972T1 (de) Verwendung von valproinsäure zur topischen behandlung von leichter bis mittelschwerer akne vulgaris
BR9713921A (pt) Composto, composição farmacêutica, processo para tógico capaz de ser modulado através da inibição do fator xa
BR0316458A (pt) Composto, composição farmacêutica, método de tratamento ou prevenção de doenças, método para intensificar a cognição em um paciente saudável, e, uso de um composto
ATE450498T1 (de) Cycloalken-dicarbonsäure-verbindungen als entzündungshemmende, immunmodulatorische und antiproliferative mittel
TR200202164T2 (tr) Matris metaloproteinaz inhibitörleri olarak kullanışlı olan hidroksamik asit bileşikleri.
ATE366107T1 (de) Verwendung von sulfodehydroabietinsäure zur behandlung entzündlicher darmerkrankungen
BR9915729A (pt) Amidas Èmega de n-arilsulfonil-aminoácido
DE69819539D1 (de) Antithrombotische mittel
WO2002064552A8 (en) 1g(a)-AMINO-N-HYDROXY-ACETAMIDE DERIVATIVES
BR0317834A (pt) Diamidas de ácido pirimidin-4,6-dicarboxìlico como inibidores mmp 13 seletivos
DE69828522D1 (de) Antithrombotische mittel
AU2003216965A1 (en) Compounds, particularly of urea derivatives or ester derivatives of haloacetamidobenzoic acid and use thereof for the treatment of parasitic diseases

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B25C Requirement related to requested transfer of rights

Owner name: JORGE ELIAS KALIL-FILHO (BR/SP) , PATRICE LEPAPE (

Free format text: A FIM DE ATENDER A(S) TRANSFERENCIA(S), REQUERIDA(S) ATRAVES DA PETICAO NO 020130013112- RJ, DE 18/02/2013, E NECESSARIO REAPRESENTAR O DOCUMENTO DE CESSAO COM A NOTARIZACAO DAS ASSINATURAS DO CEDENTE E DOS CESSIONARIOS, NOS MOLDES DO 6O, ART. 16, DA LEI DE PROPRIEDADE INDUSTRIAL.

B25A Requested transfer of rights approved

Owner name: JORGE ELIAS KALIL-FILHO (BR/SP) , ESTHER SUZY ARLE

B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL